Sarcoidosis is a systemic disease of unknown etiology defined by the presence of
noncaseating granulomatous inflammation that can cause organ damage and diminished …

Sarcoidosis affects the nervous system in 10% of cases. When it does so it can affect any
part of the nervous system and with all degrees of severity. It forms part of the differential …

Introduction Neurosarcoidosis is a rare granulomatous disorder, and treatment guidelines
are mainly based on retrospective studies. Materials and methods This retrospective study …

Introduction: Sarcoidosis is a multi-organ disease with a wide range of clinical
manifestations and outcomes. A quarter of sarcoidosis patients require long-term treatment …

Sarcoidosis affects the nervous system in 5% of cases. 60% of cases involve the cranial and
peripheral nerves, the remainder the central nervous system, in which a leptomeningitis, a …

Objectives To evaluate the clinical outcomes and relapse rates in neurosarcoidosis patients
administered infliximab. Methods A systematic review was conducted using the MEDLINE …

This is a brief and purposefully practical approach to the therapeutic and rehabilitative
management of patients affected by neurological complications of systemic sarcoidosis. The …

Migraine and sarcoidosis are two distinct medical conditions that may have some common
biological and clinical pathways. Sarcoidosis is a chronic granulomatous disease …

Background The treatment paradigm for multiple sclerosis (MS), particularly relapsing-
remitting MS, is heavily reliant on biologic disease-modifying therapies (DMTs). However …

Sarcoidosis is a rare systemic inflammatory disease characterized by the presence of
noncaseating granulomas in affected organs. 1, 2 The lungs are affected in more than 90 …